Cost-sharing and pharmaceutical utilisation and expenditure in Russia

Andrew Street, Andrew Jones, Aya Furuta

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)


This paper presents estimates of the impact of exemption status, and other socio-economic variables, on pharmaceutical use in Russia. Estimates are derived from a newly collected household survey covering around four thousand households. Separate results for a zero-inflated negbin model of utilisation of prescriptions and for a two-part model of the overall level of household expenditure on pharmaceuticals are presented. Full exemption from prescription charges is shown to increase the utilisation of prescription items and reduce the probability of the households incurring drug expenditure.

Original languageEnglish
Pages (from-to)459-472
Number of pages14
JournalJournal of Health Economics
Issue number4
Publication statusPublished - Aug 1999
Externally publishedYes


  • Copayments
  • Cost sharing
  • Count data
  • Pharmaceuticals
  • Russia
  • User charges

Cite this